Please use this identifier to cite or link to this item: http://hdl.handle.net/2445/185447
Full metadata record
DC FieldValueLanguage
dc.contributor.authorLuca, Maria De-
dc.contributor.authorLucchesi, Daniela-
dc.contributor.authorTuberoso, Carlo Ignazio Giovanni-
dc.contributor.authorFernández Busquets, Xavier-
dc.contributor.authorVassallo, Antonio-
dc.contributor.authorMartelli, Giuseppe-
dc.contributor.authorFadda, Anna Maria-
dc.contributor.authorPucci, Laura-
dc.contributor.authorCaddeo, Carla-
dc.date.accessioned2022-05-10T08:02:08Z-
dc.date.available2022-05-10T08:02:08Z-
dc.date.issued2022-04-24-
dc.identifier.issn1999-4923-
dc.identifier.urihttp://hdl.handle.net/2445/185447-
dc.description.abstractMany substances in plant extracts are known for their biological activities. These substances act in different ways, exerting overall protective effects against many diseases, especially skin disorders. However, plant extracts’ health benefits are often limited by low bioavailability. To overcome these limitations, drug delivery systems can be employed. In this study, we evaluated the antioxidant power of an ethanolic extract from Myrtus communis L. (myrtle) berries through colorimetric tests (DPPH and FRAP). The antioxidant activity was also verified by using fibroblast cell culture through cellular Reactive Oxygen Species (ROS) levels measurements. Moreover, the myrtle extract was formulated in phospholipid vesicles to improve its bioavailability and applicability. Myrtle liposomes were characterized by size, surface charge, storage stability, and entrapment efficiency; visualized by using cryo-TEM images; and assayed for cytocompatibility and anti-ROS activity. Our results suggest that myrtle liposomes were cytocompatible and improved the extract’s antioxidant power in fibroblasts, suggesting a potential skin application for these formulations and confirming that nanotechnologies could be a valid tool to enhance plant extracts’ potentialities.-
dc.format.extent12 p.-
dc.format.mimetypeapplication/pdf-
dc.language.isoeng-
dc.publisherMDPI AG-
dc.relation.isformatofReproducció del document publicat a: https://doi.org/10.3390/pharmaceutics14050910-
dc.relation.ispartofPharmaceutics, 2022, vol.14, num. 5, p. 910-
dc.relation.urihttps://doi.org/10.3390/pharmaceutics14050910-
dc.rightscc by (c) Luca, Maria De et al., 2022-
dc.rights.urihttp://creativecommons.org/licenses/by/3.0/es/*
dc.sourceArticles publicats en revistes (Institut de Bioenginyeria de Catalunya (IBEC))-
dc.subject.classificationLiposomes-
dc.subject.classificationAntioxidants-
dc.subject.classificationMalalties de la pell-
dc.subject.classificationCompostos bioactius vegetals-
dc.subject.otherLiposomes-
dc.subject.otherAntioxidants-
dc.subject.otherSkin diseases-
dc.subject.otherPlant bioactive compounds-
dc.titleLiposomal Formulations to Improve Antioxidant Power of Myrtle Berry Extract for Potential Skin Application-
dc.typeinfo:eu-repo/semantics/article-
dc.typeinfo:eu-repo/semantics/publishedVersion-
dc.date.updated2022-05-10T06:02:39Z-
dc.rights.accessRightsinfo:eu-repo/semantics/openAccess-
dc.identifier.idimarina6550176-
Appears in Collections:Articles publicats en revistes (ISGlobal)
Articles publicats en revistes (Institut de Bioenginyeria de Catalunya (IBEC))

Files in This Item:
File Description SizeFormat 
2022_Pharmaceutics_Liposomal_FernandezX.pdf2.65 MBAdobe PDFView/Open


This item is licensed under a Creative Commons License Creative Commons